Market Value375,143,000
Total Holdings57
File Date2022-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TERN / Terns Pharmaceuticals, Inc.
AVDL / Avadel Pharmaceuticals plc
BLSA / BCLS Acquisition Corp - Class A
STRO / Sutro Biopharma, Inc.
KRON / Kronos Bio, Inc.
EQ / Equillium, Inc.
NGM / NGM Biopharmaceuticals, Inc.
ACRS / Aclaris Therapeutics, Inc.
LYRA / Lyra Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
RXRX / Recursion Pharmaceuticals, Inc.
ALVR / AlloVir, Inc.
ALLK / Allakos Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
RYTM / Rhythm Pharmaceuticals, Inc.
JYAC / Jiya Acquisition Corp - Class A
HLVX / HilleVax, Inc.
SRRK / Scholar Rock Holding Corporation
NKTX / Nkarta, Inc.
ALXO / ALX Oncology Holdings Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
SRZNW / Surrozen, Inc. - Equity Warrant
DAWN / Day One Biopharmaceuticals, Inc.
JANX / Janux Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ODTC / Odonate, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
VTGN / Vistagen Therapeutics, Inc.
SRZN / Surrozen, Inc.
ATXS / Astria Therapeutics, Inc.
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
KDNY / Chinook Therapeutics Inc
EYPT / EyePoint, Inc.
ACLX / Arcellx, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
IOBT / IO Biotech, Inc.
NVAX / Novavax, Inc. Call
NVAX / Novavax, Inc.
ALBO / Albireo Pharma Inc
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
PEPG / PepGen Inc.
ICPT / Intercept Pharmaceuticals Inc
FMTX / Forma Therapeutics Holdings Inc
ISEE / IVERIC bio Inc
AGLE / Aeglea BioTherapeutics Inc
ZYME / Zymeworks Inc.
GRPH / Graphite Bio, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
LSAQ / LifeSci Acquisition II Corp
ELEV / Elevation Oncology, Inc.
SYRS / Syros Pharmaceuticals, Inc.
VTVT / vTv Therapeutics Inc.
KALA / KALA BIO, Inc.
DBTX / Decibel Therapeutics Inc
DICE / DICE Therapeutics Inc
TIL / Instil Bio, Inc.
BCEL / Atreca, Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
IGMS / IGM Biosciences, Inc.
TNGX / Tango Therapeutics, Inc.
VIRX / Viracta Therapeutics, Inc.